Results 131 to 140 of about 309,604 (286)
Aims Prescribing is a complex, essential skill that doctors must acquire to practice medicine safely and effectively. The British Pharmacological Society has historically provided a core curriculum to guide clinical pharmacology and prescribing education in UK medical schools.
Dagan O. Lonsdale +5 more
wiley +1 more source
Patients' Perceptions on Community Pharmacy Services of a Ward (10) of Kathmandu Metropolitan. [PDF]
Ojha A, Bista D, Kc B.
europepmc +1 more source
Aims Amoxicillin, a widely used β‐lactam antibiotic, requires improved pharmacokinetic characterization during breastfeeding. This study used a population pharmacokinetic (PopPK) approach to model amoxicillin concentrations in breast milk, identify variability sources and estimate infant exposure, applying worst‐case scenarios.
Sarah Baklouti +9 more
wiley +1 more source
Community pharmacy services during the COVID-19 pandemic: Insights from providers and policy makers. [PDF]
Warr H +3 more
europepmc +1 more source
Dosing Biologic Drugs for Patients With Obesity: One Size Does Not Fit All
Arthritis &Rheumatology, EarlyView.
Stephen J. Balevic +2 more
wiley +1 more source
Aim To explore the practices, confidence and perspectives of community pharmacists in deprescribing high‐risk psychotropic medicines, including opioid analgesics, benzodiazepine, gabapentinoids and medicinal cannabis. Methods An anonymous, cross‐sectional national online survey was conducted between January and April 2025 among Australian community ...
Monica Jung +5 more
wiley +1 more source
Background Healthcare systems globally are expanding community pharmacy services to meet patient needs and reduce healthcare costs. In England this includes helping community pharmacies to provide integrated professional services but concerns persist ...
Ali M. K. Hindi +2 more
doaj +1 more source
Background: Currently, polypharmacy is common among residents at high risk of unsafe medication practices, partly due to a lack of medication reconciliation and comprehensive medication management.
Rui LIU, Yu CAO, Aiqun CHU, Huanyun WU
doaj +1 more source
Zuranolone: A case study in (regulatory) rush to judgement?
Abstract Sage, in collaboration with Biogen, submitted a new drug approval for zuranolone for postpartum depression (PPD) and major depressive disorder (MDD) in December 2022. In August 2023, the US Food and Drug Administration granted approval for PPD but denied approval for MDD.
Lisa Cosgrove +4 more
wiley +1 more source
Community pharmacists' perspectives towards automated pharmacy systems and extended community pharmacy services: An online cross-sectional study. [PDF]
Alghamdi KS +5 more
europepmc +1 more source

